Who owns Entrada Therapeutics Inc (TRDA)? Superinvestor holders
1 superinvestor of the 157 tracked here holds Entrada Therapeutics Inc (TRDA) in their latest 13F filing, a position of $37.3M. Julian and Felix Baker gives it the most weight: 0.19% of the reported portfolio. Chuck Royce (founder) sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 1 of 157
- Biggest holder
- Julian and Felix Baker, $37.3M
- Largest weight
- Julian and Felix Baker, 0.19%of their portfolio
- Combined value
- $37.3M
- Bought last quarter
- 0
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Julian and Felix BakerBaker Bros. Advisors | 0.19% | $37.3M | 5.07M | No change | 0 | Q2 2026 |
Sold out last quarter
- Chuck Royce (founder)was $610.2K · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 0 | — | — | 0 | 1 |
| Q2 2026 | 157 | 1 | 5.07M | $37.3M | 0 | 0 |
| Q1 2026 | 157 | 1 | 5.07M | $64M | 0 | 0 |
| Q4 2025 | 157 | 1 | 5.07M | $52.1M | 1 | 0 |
| Q3 2025 | 157 | 1 | 4.87M | $28.2M | 0 | 0 |
| Q2 2025 | 157 | 1 | 4.87M | $32.7M | 0 | 0 |
| Q1 2025 | 156 | 1 | 4.87M | $44M | 0 | 0 |
| Q4 2024 | 156 | 1 | 4.87M | $84.1M | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Julian and Felix Baker | · | 5.07M | 5.07M | 5.07M | 4.87M | 4.87M | 4.87M | 4.87M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own TRDA?
In their latest 13F filings: Julian and Felix Baker (0.19% of the portfolio, $37.3M).
Who sold TRDA last quarter?
Sold out entirely: Chuck Royce (founder) (was $610.2K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Entrada Therapeutics Inc (TRDA)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/TRDA/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to TRDA by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.